Risk-benefit analysis of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes

Author: Westerhout Cynthia M   Boersma Eric  

Publisher: Informa Healthcare

ISSN: 1474-0338

Source: Expert Opinion on Drug Safety, Vol.2, Iss.1, 2003-01, pp. : 49-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract